| News

Patients stand to benefit from innovative tech project

11.12.2020

The investment and innovation promotion agency Basel Area Business & Innovation is joining forces with several partners to realize a technology project. For this, an app aimed at supporting oncology patients is being developed.

Version under development of the app for patients of the Hospital of Jura

The Hospital of Jura (H-JU) will be realizing four joint projects together with Basel Area Business & Innovation over the next four years. For the first, the two partners have also brought on board the University Hospital Basel (USB) and Haute Ecole Arc (HE-Arc). For this inter-cantonal technology project, an app is being developed for oncology patients. This is aimed at providing an improved overview of upcoming doctor’s appointments and treatments for users. The Swiss federal government and the canton of Jura have provided financial backing for the project, as detailed in a press release.

The patients in question from the canton of Jura are being treated at either the H-JU in Delémont or the USB in Basel. For this reason, an overview of appointments as well as information on the various institutions is important for the patients. The app should not only display these appointments and remind users of these, but will also be shared with other relatives. In addition, any entries and notifications about prescribed medication and treatments can be accessed here. The new app is rounded off by providing further information on the respective illness. In this way, individual information can be sent to the patient, which should also lead to faster reactions.

Basel Area Business & Innovation is the initiator of the project and will also be responsible for coordinating it. Given that the relevant pre-planning has already been carried out with developers, software ergonomics specialists and engineering students from HE-Arc at Switzerland Innovation Park Basel Area in Courroux in the canton of Jura, the test phase is set to begin before the end of this year. In a next step, a company from Jura will be tasked with developing a marketing concept. In future, the app should be available for other hospitals and medical practices, including for other medical disciplines.

Share this article

Sign up to receive our newsletter in your inbox.

You may also be interested in

Basel startups impress investors
Basel Area Business & Innovation, Innovation, Invest, Switzerland Innovation Park

Basel startups impress investors

According to the latest Swiss Venture Capital Report, investments in Swiss startups increased by 44 percent last year. As a...

Read More
Basel Area – exactly the right chemistry for South Korean pharma companies
Basel Area Business & Innovation, Innovation, Invest

Basel Area – exactly the right chemistry for South Korean pharma companies

KPBMA and Basel Area Business & Innovation establish tailored collaboration to support Korean biopharmaceutical companies to enter the European market

Read More
Basel Area supporting three digital health startups
Basel Area Business & Innovation, Innovation, Invest, Switzerland Innovation Park

Basel Area supporting three digital health startups

Basel Area Business & Innovation will be offering intensive support to the three winners of its DayOne Digital Health Accelerator...

Read More
Gray establishes presence in Basel
Basel Area Business & Innovation, Innovation, Invest

Gray establishes presence in Basel

The North American fully integrated specialty service provider Gray has established a subsidiary in Basel. The key factors in favor...

Read More
Artificial Intelligence able to identify potentially life-saving antibiotics
Basel Area Business & Innovation, Innovation, Invest

Artificial Intelligence able to identify potentially life-saving antibiotics

A computer algorithm has identified antibiotics that that are still effective against infections in which multi-resistant germs are present. University...

Read More
Investors give Anaveon 110 million Swiss francs
Basel Area Business & Innovation, Innovation, Invest

Investors give Anaveon 110 million Swiss francs

Anaveon has received investment commitments amounting to 110 million Swiss francs in a Serie B funding round. The Basel-based biopharmaceutical...

Read More
1 2 3 52

Do you have a question? We'd like to hear from you.